ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option
₹41.4100
₹0.53 (-1.26%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹41.4100
₹0.53 (-1.26%)
29 May 2026
AMFI: 143873
Direct · Growth
₹₹44.9300
₹0.57 (-1.25%)
29 May 2026
AMFI: 143874
Regular · IDCW
₹₹24.3700
₹0.40 (+1.67%)
14 May 2026
AMFI: HIST_CAMS_INF109KC1GF6
Direct · IDCW
₹₹27.1400
₹0.34 (-1.24%)
29 May 2026
AMFI: 143876
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹100/month became
Real NAV backtest from day one
₹9,400
Invested
₹21,840
Value today
21.0%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹5,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹5,000
Invested
₹20,705
Value today
19.8%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹4,70,000
Withdrawn
₹30,49,004
Corpus left
+₹25,19,004 net gain — withdrew ₹4,70,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹24,85,918
Value today
+0.1%
vs lumpsum
STP beat direct lumpsum by 0.1% — reduced timing risk paid off
Model your own STP with real NAVBeat the benchmark — ₹100/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹21,840
Benchmark
₹16,445
+₹5,395 extra wealth vs the benchmark index
Backtest this SIP yourself₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹4,68,439
Value today
4.7×
Multiple
Staying invested through that crash turned ₹1L into ₹4,68,439 — a 4.7× return
Read: Staying invested through crashesDirect vs Regular — ₹500/month over 7 years
Expense ratio drag on your actual returns
Direct plan
₹94,545
Regular plan
₹90,849
Direct earns ₹3,696 more on a ₹42K investment — 1.26% extra return per year
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised0.09
Sharpe Ratio
+0.06
Alpha
0.36
Beta
0.09
Sortino
15.22%
Std Dev
-16.32%
Max Drawdown
Portfolio Holdings
Top 38 holdings · as of Apr 2026
| Security | % NAV |
|---|---|
Sun Pharmaceutical Industries Ltd. INE044A01036 | 11.76% |
Cipla Ltd. INE059A01026 | 8.15% |
Mankind Pharma Ltd. INE634S01028 | 7.58% |
Divi's Laboratories Ltd. INE361B01024 | 6.06% |
Dr. Reddy's Laboratories Ltd. INE089A01031 | 5.94% |
Biocon Ltd. INE376G01013 | 5.81% |
Cohance Lifesciences Ltd. INE03QK01018 | 4.44% |
Lupin Ltd. INE326A01037 | 3.80% |
Medplus Health Services Ltd INE804L01022 | 3.37% |
Alkem Laboratories Ltd. INE540L01014 | 3.24% |
Syngene International Ltd. INE398R01022 | 3.09% |
Akums Drugs and Pharmaceuticals Ltd. INE09XN01023 | 2.02% |
Pfizer Ltd. INE182A01018 | 1.96% |
Aurobindo Pharma Ltd. INE406A01037 | 1.93% |
Abbott India Ltd. INE358A01014 | 1.88% |
Thyrocare Technologies Ltd. INE594H01019 | 1.88% |
J.B.Chemicals & Pharmaceuticals Ltd. INE572A01036 | 1.77% |
Alembic Pharmaceuticals Ltd. INE901L01018 | 1.74% |
Alivus Life Sciences Ltd. INE03Q201024 | 1.72% |
Entero Healthcare Solutions INE010601016 | 1.72% |
Gland Pharma Ltd. INE068V01023 | 1.51% |
Blue Jet Healthcare Ltd. INE0KBH01020 | 1.44% |
Zydus Lifesciences Ltd. INE010B01027 | 1.36% |
Metropolis Healthcare Ltd. INE112L01020 | 1.31% |
Medi Assist Healthcare Services Ltd INE456Z01021 | 1.25% |
Fine Organic Industries Ltd. INE686Y01026 | 1.15% |
Hikal Ltd. INE475B01022 | 1.14% |
Windlas Biotech Ltd. INE0H5O01029 | 1.10% |
Aarti Drugs Ltd. INE767A01016 | 1.04% |
Sanofi Consumer Healthcare India Ltd INE0UOS01011 | 1.03% |
Anthem Biosciences Ltd INE0CZ201020 | 0.90% |
Astrazeneca Pharma India Ltd. INE203A01020 | 0.72% |
FDC Ltd. INE258B01022 | 0.66% |
Laxmi Dental Ltd. INE0WO601020 | 0.66% |
Shilpa Medicare Ltd. INE790G01031 | 0.61% |
Nephrocare Health Services Ltd INE428V01029 | 0.42% |
Sun Pharma Advanced Research Co. Ltd INE232I01014 | 0.38% |
Senores Pharmaceuticals Ltd INE0RB801010 | 0.21% |
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Investment Objective
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹6,565 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 1.86%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations